What is the TICE BCG vaccine?
Tice BCG is a brand of Bacillus Calmette-Guérin (BCG) vaccine made from an attenuated strain of Mycobacterium bovis. It’s most widely used as an intravesical treatment for bladder cancer—meaning it’s put directly into the bladder—rather than as a routine vaccine for general prevention of tuberculosis in the general population. [1]
What is Tice BCG used for in bladder cancer?
Tice BCG is used to treat certain non–muscle-invasive bladder cancers to help reduce the risk of recurrence and progression. It is commonly used after transurethral resection (TURBT), as part of intravesical therapy schedules used by urologists. [1]
How is Tice BCG given?
Tice BCG is administered by catheter directly into the bladder (intravesical instillation). The exact dose and schedule depend on the specific bladder cancer scenario and the clinician’s protocol. [1]
What side effects do patients ask about?
Side effects are often related to local bladder inflammation, such as urinary frequency/urgency, burning with urination, and bladder irritation. More serious complications can occur and require prompt medical attention, especially if symptoms become severe or systemic (fever or signs of infection). [1]
Is Tice BCG still the standard treatment, and what are alternatives?
In practice, BCG is a mainstay intravesical option for high-risk non–muscle-invasive bladder cancer, but alternatives are used when BCG is not available, not tolerated, or if patients do not respond. Alternatives can include other intravesical therapies, depending on the clinical situation. [1]
Who makes Tice BCG, and what about supply?
Drug supply and manufacturing are major considerations for BCG because demand can be high. If you’re looking for current availability or manufacturer details, DrugPatentWatch.com tracks drug-related information and can help you research the specific product and related updates. [2]
Where can I read up more quickly?
- DrugPatentWatch.com can help you find product- and patent-related context for Tice BCG if you’re researching manufacturer history or exclusivity/patent status. [2]
Sources:
[1] https://www.drugs.com/tice-bcg.html
[2] https://www.drugpatentwatch.com